First report of a clinical isolate of Candida haemulonii in Brazil

Clinics

Volumn 67, Issue 10, 2012, Pages 1229-1231

  de Almeida, João Nobrega ^a   Motta, Adriana Lopes ^a   Rossi, Flávia ^a   Abdala, Edson ^a   Pierrotti, Ligia Camera ^a   Kono, Adriana Satie Gonçalves ^a   Diz, Maria Del Pilar Estevez ^a   Benard, Gil ^a   Del Negro, Gilda Maria Barbaro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868291284     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(10)18     Document Type: Article

References (23)

1. Miceli MH, Diaz JA, Lee SA. Emerging opportunistic yeast infections. The Lancet infectious diseases. 2011;11(2):142-51, http://dx.doi.org/10.1016/S1473-3099(10)70218-8.
2. Lockhart SR, Messer SA, Pfaller MA, Diekema DJ. Identification and Susceptibility Profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates. J Clin Microbiol. 2009;47(1):242-4, http://dx.doi.org/10.1128/JCM.01889-08.
3. Chen SC, Marriott D, Playford EG, Nguyen Q, Ellis D, Meyer W, et al. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect. 2009;15(7):662-9, http://dx.doi.org/10.1111/j.1469-0691.2009.02821.x.
4. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010;48(4):1366-77, http://dx.doi.org/10.1128/JCM.02117-09.
5. Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). J Clin Microbiol. 2011;49(1):396-9, http://dx.doi.org/10.1128/ JCM.01398-10.
6. Lavarde V, Daniel F, Saez H, Arnold M, Faguer B. Peritonite mycosique a Torulopsis haemulonii. Bul Soc Fr Mycol Med. 1984;13:173-6.
7. Rodero L, Cuenca-Estrella M, Córdoba S, Cahn P, Davel G, Kaufman S, et al. Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii. J Clin Microbiol. 2002;40(6):2266-9, http:// dx.doi.org/10.1128/JCM.40.6.2266-2269.2002.
8. Giusiano G, Magianterra M, Garcia Saito V, Rojas F, Gómez V, Días MC. Fluconazole and itraconazole resistance of yeasts isolated from the bloodstream and catheters of hospitalized pediatric patients. Chemotherapy. 2006;52(5):254-9, http://dx.doi.org/10.1159/000094867.
9. Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, et al. Candida haemulonii and closely related species at wsniversity hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis. 2009;48(6):e57-61, http://dx.doi.org/10.1086/597108.
10. Ruan SY, Kuo YW, Huang CT, Hsiue HC, Hsueh PR. Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes. Int J Antimicrob Agents. 2010;35(1):85-8, http://dx.doi.org/10.1016/j.ijantimicag.2009.08.009.
11. Kim S, Ko KS, Moon SY, Lee MS, Lee MY, Son JS. Catheter-related Candidemia Caused by Candida haemulonii in a Patient in Long-term Hospital Care. J Korean Med Sci. 2011;26(2):297-300, http://dx.doi.org/10.3346/jkms.2011.26.2.297.
12. Khan ZU, Al-Sweih NA, Ahmad S, Al-Kazemi N, Khan S, Joseph L, et al. Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole. J Clin Microbiol. 2007;45(6):2025-7, http://dx.doi.org/10.1128/JCM.00222-07.
13. Crouzet J, Sotto A, Picard E, Lachaud L, Bourgeois N. A case of Candida haemulonii osteitis: clinical features, biochemical characteristics and antifungal resistance profile. Clin Microbiol Infect. 2011;17(7):1068-70, http://dx.doi.org/10.1111/j.1469-0691.2011.03471.x.
14. Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, et al. Brazilian Network Candidemia Study. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol. 2006;44(8):2816-23, http:// dx.doi.org/10.1128/JCM.00773-06.
15. Colombo AL, Guimarães T, Silva LR, de Almeida Monfardini LP, Cunha AK, Rady P, Alves T, et al. Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. Infect Control Hosp Epidemiol. 2007;28(5):570-6, http://dx.doi.org/10.1086/513615.
16. Motta AL, Almeida GM, de Almeida Jú nior JN, Burattini MN, Rossi F. Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex. Braz J Infect Dis. 2010;14(5):441-8, http://dx.doi.org/10.1590/S1413-86702010000500004.
17. Pereira GH, Müller PR, Szeszs MW, Levin AS, Melhem MS. Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candida species. Med Mycol. 2010;48(6):839-42, http://dx.doi.org/10.3109/13693780903580121.
18. Loffler J, Hebart H, Schumacher U, Reitze H, Einsele H. Comparison of different methods for extraction of DNA of fungal pathogens from cultures and blood. J Clin Microbiol 1997;35:3311-2.
19. Luo G, Mitchell TG. Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J Clin Microbiol. 2002;40(8):2860-5, http://dx.doi.org/10.1128/JCM.40.8.2860-2865.2002.
20. Clinical Laboratory Standards Institute. Reference Method for Broth Diluiton Antifungal Susceptibility Testing of Yeasts; Approved Standard-Third Edition. CLSI document M27-A3. Wayne, PA: CLSI, 2008.
21. Oh BJ, Shin JH, Kim MN, Sung H, Lee K, Joo MY, et al. Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. Med Mycol. 2011;49(1):98-102, http://dx.doi.org/10.3109/13693786.2010.493563.
22. Hospenthal DR, Murray CK, Beckius ML, Green JA, Dooley DP. Persistence of pigment production by yeast isolates grown on CHROMagar Candida medium. J Clin Microbiol. 2002;40(12):4768-70, http://dx.doi.org/10.1128/JCM.40.12.4768-4770.2002.
23. Clinical Laboratory Standards Institute. Interpretative Criteria for Identification of Bacteria and Fungi by DNA Target Sequencing; Approved Guideline. CLSI document MM18-A.: Wayne, PA: CLSI, 2008.